Acute gout attacks · people with chronic gout
Allopurinol showed no clear difference in acute gout attacks compared with placebo (moderate certainty).
1 finding from 1 review
Acute gout attacks · people with chronic gout
Allopurinol showed no clear difference in acute gout attacks compared with benzbromarone (low certainty).
1 finding from 1 review
Proportion achieving target serum urate · people with chronic gout
Allopurinol showed no clear difference in proportion achieving target serum urate compared with benzbromarone (moderate certainty).
1 finding from 1 review
Pain reduction ‐ not measured · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Function ‐ not measured · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Tophus regression ‐ not measured · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Proportion achieving target serum urate · people with chronic gout
Allopurinol probably leads to higher proportion achieving target serum urate compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with chronic gout
Allopurinol showed no clear difference in withdrawal due to adverse events compared with benzbromarone (low certainty).
1 finding from 1 review
Serious adverse effects · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Pain reduction · people with chronic gout
1 finding from 1 review
Function · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Tophus regression · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · people with chronic gout
Allopurinol showed no clear difference in withdrawal due to adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · people with chronic gout
Allopurinol showed no clear difference in serious adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Clinical remission · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maintenance of clinical remission · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
No episodes of acute pouchitis · Patients with ileal pouch‐anal anastomosis
Allopurinol showed no clear difference in no episodes of acute pouchitis compared with placebo (low certainty).
1 finding from 1 review
Adverse events · Patients with ileal pouch‐anal anastomosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prostatitis symptoms · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review